Lycopene Oxidation, Uptake, and Activity in Human Prostate Cell Cultures - Carotenoids: Physical, Chemical, and Biological Functions and Properties - page 462

Kotake-Nara, E, JS Kim, M Kobori, K Miyashita, and A Nagao. 2002. Acylo -retinoic acid induces apoptosis in
human prostate cancer cells. Anticancer Res 22(2A):689-95.
Kotake-Nara, E, M Kushiro, Zhang H, T Sugawara, K Miyashita, and A Nagao. 2001. Carotenoids affect pro-
liferation of human prostate cancer cells. J Nutr 131:3303-3306.
Kozuki, Y, Y Miura, and K Yagasaki. 2000. Inhibitory effects of carotenoids on the invasion of rat ascites hepa-
toma cells in culture. Cancer Lett 151:111-115.
Kravets, FG, J Lee, B Singh, A Trocchia, SN Pentyala, and S Khan. 2000. Prostasomes: Current concepts.
Prostate 43:169-174.
Li, L, H Ya, F Schumacher, G Casey, and JS Witte. 2003. Relations of serum insulin-like growth factor-1-
(IGF-1) and IGF binding protein-3 to risk of prostate cancer(United States). Cancer Causes Control
14:721-726.
Lin C-Y, Huang C-S, and Hu M-L. 2007. The use of fetal bovine serum as delivery vehicle to improve the
uptake and stability of lycopene in cell culture studies. Br J Nutr 98:226-232.
Lin, X, M Tascilar, WH Lee et al. 2001. GSTP1 CpG island hypermethylation is responsible for the absence of
GSTP1 expression in human prostate cancer cells. Am J Pathol 159:1815-1826.
Lindshield, BL, K Canene-Adams, and JW Erdman. 2007. Lycopenoids: Are lycopene metabolites bioactive?
Arch Biochem Biophys 458:136-140.
Liu, A, N Pajkovic, Y Pang, D Zhu, B Calamini, AL Mesecar, and RB van Breemen. 2006. Absorption and
subcellular localization of lycopene in human prostate cancer cells. Mol Cancer Ther 5(11):2879-2885.
Liu, X, JD Allen, JT Arnold, and MR Blackman. 2008. Lycopene inhibits IGF-1 signal transduction and growth
of normal prostate epithelial cells by decreasing DHT-modulated IGF-1 production in cocultured reactive
stromal cells. Carcinogenesis 29(4):816-823.
Livny, O, I Kaplan, R Reifen, S Polak-Charcon, Z Madar, and B Schwartz. 2003. Oral cancer cells differ from
normal oral epithelial cells in tissuelike organization and in response to lycopene treatment: An organo-
typic cell culture study. Nutr Cancer 47(2):195-209.
Lo, H-M, C-F Hung, Y-L Tseng, B-H Chen, J-S Jian, and W-B Wu. 2007. Lycopene binds PDGF-Bb and inhib-
its PDGD-BB-induced intracellular signaling transduction pathway in rat smooth muscle cells. Biochem
Pharmacol 74:54-63.
Lodi, F, R Jimenez, C Menendez, PW Needs, J Buaret, and E Perez-Vizcaino. 2008. Glucuronidated metabo-
lites of the l avonoid of quercetin do not auto-oxidize, do not generate free radicals and do not decrease
nitric oxide bioavailability. Planta Med 74(7):741-746.
Lowe, GM, LA Booth, AJ Young, and R Bilton. 1999. Lycopene and beta-carotene protect against oxidative
damage in HT29 cells at low concentrations but rapidly lose this capacity at higher doses. Free Radic
Res 30:141-151.
Matos, HR, P Di Mascio, and MHG Medieros. 2000. Protective effect of lycopene on lipid peroxidation and
oxidative DNA damage in cell culture. Arch Biochem Biophys 383(1):56-59.
Mercurio, F and AM Manning. 1999. NF-kappa B as a primary regulator of the stress response. Oncogene
18:6163-6171.
Metivier, R, R Gallais, C Tiffoche et al. 2008. Cyclical DNA methylation of a transcriptionally active promoter.
Nature 452:45-50.
Miki, J and JS Rhim. 2007. Prostate cell cultures as in vitro models for the study of normal stem cells and can-
cer stem cells. Prostate Cancer Prostatic Dis 11(1):32-39.
Miyata, Y, H Sakai, T Hayashi, and H Kanetake. 2003. Serum insulin-like growth factor binding protein-3/
prostate-specii c antigen ratio is a useful predictive marker in patients with advanced prostate cancer.
Prostate 54:125-132.
Moon, YJ, L Wang, R DiCenzo, and ME Morris. 2008. Quercetin pharmacokinetics in humans. Biopharm Drug
Dispos 29:205-217.
Mucci, LA, R Tamimi, P Lagiou et al. 2001. Are dietary inl uences on the risk of prostate cancer mediated
through the insulin-like growth factor system. BJU Int 87:814-820.
Murphy, TM, AS Perry, and M Lawler. 2008. The emergence of DNA methylation as a key modulator of aber-
rant cell death in prostate cancer. Endocr Relat Cancer 15:11-25.
Nagao A 2004. Oxidative conversion of carotenoids to retinoids and other products. J Nutr 143:237s-240s.
Nahum A, Kirsch K, Danilenko M et al. 2001. Lycopene inhibition of cell cycle progression in breast and
endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27-Kip1 in the
cyclin E-cdk2 complexes. Oncogene 20:3428-3436.
Nara, E, H Hayashi, M Kotake, K Miyashita, and A Nagao. 2001. Acyclic carotenoids and their oxidation mix-
tures inhibit the growth of HL-60 human promyelocytic leukemia cells. Nutr Cancer 39(2):273-83.